News zur CELLINK AKTIE ✓ und aktueller Realtime-Aktienkurs ✓ CELLINK AB: CELLINK receives the prestigious gold award for the BIO X6 and wins two
8 May 2020 H2020,CENSUS,FTIPilot-01-2016,TISSUE CLICK LTD(UK),PHENOCELL(FR), CELLINK AB(SE),AvantiCell Science Ltd(UK)
Se omsättning, bokslut, styrelse, m.m, Ladda ner gratis årsredovisningar. 2021-04-08 Cellink AB (publ), a bio convergence company, designs and develops bioprinting, liquid handling, single-cell analysis, and live-cell imaging technologies in North America, Europe, Asia, and internationally. More Details. Rewards. Earnings are forecast to grow 158.85% per year.
B-aktien är noterad på Nasdaq Stockholm (Nordiska listan) 2020. Ny notering på Nasdaq Stockholm den 20 april. Överförd från First North. Cellink AB gick med vinst (2019) Cellink AB gick med vinst, 1 261 000 kr. Cellink AB ökade sin omsättning med 79,52% senaste räkenskapsåret.
17 Mar 2021 Today CELLINK releases its annual report for the 2019-2020 year. Learn how we 've CELLINK-AB-publ-Annual-Report-201… סרטונים קשורים
… Growth Analysis of Cellink AB ( CLNK.B | SWE) The Growth Score is a relevant measure for the assessment of a stock attractiveness. Cellink AB shows a Growth Score of 8.00. The Growth Score for Cellink AB is significantly higher than its peer group's. This means that Cellink AB has a significantly higher growth than its peer group.
Det världsledande biokonvergensföretaget CELLINK AB (publ), grundades 2016 och tillhandahåller teknik, produkter och tjänster för att skapa, förstå och behärska biologi.
2021-04-08 Cellink AB (publ), a bio convergence company, designs and develops bioprinting, liquid handling, single-cell analysis, and live-cell imaging technologies in North America, Europe, Asia, and internationally. More Details. Rewards. Earnings are forecast to grow 158.85% per year. CELLINK Antal aktier * 6 895 847 Börsvärde (MSEK) * 179,3 Nettokassa (MSEK) 28,69 EV (MSEK) * 150,6 Handelsplats First North Datum för nästa rapport 18:e januari 2017 HUVUDÄGARE Erik Gatenholm 40,98 %* Hector Martinez 27,20 %* Fore C Investment(Göran Nordlund) 10,66 %* Carl Bennet AB 3,96 %* Gusten Danielsson 3,4 %* Jockum Svanberg 3,06 % 2021-03-12 01:30:00 Cellink AB: CELLINK AB announces the completion of the offering of Senior Unsecured Convertible Bonds convertible into Class B shares and a Class B share issue in an overall amount of SEK 3.0 billion-0,11% | 394 MSEK 2020-08-28 2 VIKTIG INFORMATION INVESTERINGSMEMORANDUM CELLINK AB ALLMÄNT Detta investeringsmemorandum (“Memorandumet”) har upprättats med anledning av Bolagets erbjudande om teckning av aktier i CEL-LINK AB (publ), (“CELLINK” eller ”Bolaget”) org.nr 559050-5052, samt ansökan om upptagande till handel av Bolagets aktier på Nasdaq First North. 1 day ago CELLINK AB (publ) ("CELLINK") har ingått avtal med aktieägarna till Ginolis Oy ("Ginolis"), ett finskt företag med inriktning på automatiserad diagnostik och avancerade robotiklösningar till medicinsk- och diagnostisk industri, om att förvärva samtliga aktier till en köpeskilling på kassa- och skuldfri basis uppgående till 70 miljoner euro ("Förvärvet"). Köp aktien CELLINK AB ser.
Quote Stock Analysis News Price vs Fair Value Trailing Returns Financials Valuation Operating Performance Dividends
CELLINK AB (publ) (”CELLINK” eller ”Bolaget”) (Bolagets aktier handlas på Nasdaq First North Growth Market under kortnamnet CLNK B) meddelade den 3 april 2020 att Nasdaq Stockholms bolagskommitté godkänt att Bolagets aktier tas upp till handel på Nasdaq Stockholms huvudlista, förutsatt att sedvanliga villkor uppfylldes. Cellink is a bioconvergence startup that designs and supplies technologies and services to enhance biology research. It focuses on commercializing technologies for life science research as well as bioprinting, and its products often combine capabilities in artificial intelligence, robotics, multiomics, and diagnostics. Cellink began by producing bio-inks and bioprinters for culturing different cell types to …
Cellink AB (publ) (STO:CLNK B) shareholders will have a reason to smile today, with the covering analyst making substantial upgrades to next year's forecasts. Consensus estimates suggest investors could expect greatly increased statutory revenues and earnings per share, with the analyst modelling a real improvement in business performance.
Franklin tn
3 Feb 2020 CELLINK announces extension of collaboration with AstraZeneca to use CELLINKs' technologies for preparation and analysis of 3D-bioprinted tissues, Erik Penser Bank AB is the Company's certified adviser, avai 8 May 2020 H2020,CENSUS,FTIPilot-01-2016,TISSUE CLICK LTD(UK),PHENOCELL(FR), CELLINK AB(SE),AvantiCell Science Ltd(UK) Eine Basis-Recherche ist die Analyse von Aktien aus dem gleichen Sektor oder der gleichen Branche. Zudem bietet die Zugehörigkeit eines Titel zu Anlage- 8 May 2020 H2020,CENSUS,FTIPilot-01-2016,TISSUE CLICK LTD(UK),PHENOCELL(FR), CELLINK AB(SE),AvantiCell Science Ltd(UK) 22. Mai 2020 in folgender Cellink Aktienanalyse schauen wir auf eine junge Firma, welche Bis 2018 befand sich der Kurs zwischen 32 SEK – 44 SEK und hat ab 2019 eine weitere Preis DAX-Analyse zum Donnerstag, den 01.04.2021 Cellink AB. Erik Gatenholm and CELLINK awarded the SVD Business Award 2020 (Cision). 2020-05-20 12:15. Yesterday, Prince Daniel of Sweden revealed Stammdaten.
Grundlig översikt över nyckeltal och ekonomi för CELLINK AB (CLNK B) på MSN Ekonomi. Growth Analysis of Cellink AB ( CLNK.B | SWE) The Growth Score is a relevant measure for the assessment of a stock attractiveness.
Hur bra är ica försäkring
alfakassan kontakt
tullkriminalen husrannsakan
ken loach new
snabbkurs i historia
robert gustafsson finsk fylla
lisa ajax melodifestivalen dansare
Growth Analysis of Cellink AB ( CLNK.B | SWE) The Growth Score is a relevant measure for the assessment of a stock attractiveness. Cellink AB shows a Growth Score of 8.00. The Growth Score for Cellink AB is significantly higher than its peer group's. This means that Cellink AB has a significantly higher growth than its peer group.
Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment CELLINK AB is the bio-convergence company. It provides technologies, products and services to create, understand and master biology. With a focus on the Analyst, Potential (Euro), Potential, Zeit.
Björn rosengren boxning
weather in gothenburg sweden
Analyshuset uppdaterar sin rekommendation behåll för aktien och sätter riktkursen 260 kronor. Det kan jämföras behov av att. COT-Clean Oil Technology AB Påskskjuts på börsen – köpråd lyfte både Dustin och Cellink.
founded in 2016 with the vision to “create the future of medicine” by analysing and. processing information through 3D-bioprinting. Cellink Some of the innovations showcased are Cellink, a bio-tech company that invented the revolutionary bio printer BIO X and the world's first universal bio-ink, CELLINK: EBITDA-MARGINAL ÖKADE TILL 4,6% 4 KV STOCKHOLM (Direkt) First North-bolaget Cellink 23 oktober 2018 kommenterade CELLINK AB ser. B BOOZT AB BRAVIDA HOLDING AB BURE EQUITY AB BYGGMAX GROUP AB CASTELLUM AB CATENA AB CELLAVISION AB CELLINK AB FINANCE MANAGER AT CELLINK - BUSINESS UNIT BIOPRINTING. Cellink.